Samsung Biologics engages suppliers to advance global decarbonization targets

The company invited supplier companies and external ESG specialists to discuss ESG-related requirements and recommendations as well as share successful cas...

November 28, 2023 | Tuesday | News
Seegene Boosts ESG Rating by Korea Institute of Corporate Governance and Sustainability

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced on November 10 that it has rece...

November 24, 2023 | Friday | News
AI-Powered Immune Phenotyping by Lunit SCOPE IO Marks First TKI-Resistant Lung Cancer Immunotherapy Success

Lunit SCOPE IO pivotal in first phase III trial successfully showing the efficacy of immunotherapy + chemotherapy for NSCLC patients with EGFR or ALK mut...

October 25, 2023 | Wednesday | News
SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023

  With a dedicated booth in the main exhibition hall, SK pharmteco solidifies its global position as the most trusted CDMO partner in the pharmaceu...

October 20, 2023 | Friday | News
Samsung Bioepis Presents Phase 1 and 3 Clinical Results for SB16 Biosimilar to Prolia at ASBMR 2023

Phase 1 study for SB16, proposed biosimilar to Prolia, demonstrates pharmacokinetic (PK) bioequivalence between SB16, EU-sourced denosumab, and US-source...

October 16, 2023 | Monday | News
Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy

.. First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progression f...

October 13, 2023 | Friday | News
Clearside Biomedical Announces Advancement of XIPERE® in Asia-Pacific

Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the su...

October 05, 2023 | Thursday | News
SK Pharmteco Expands with Controlling Stake in Center for Breakthrough Medicines

CBM brings extensive cell and gene therapy expertise to SK pharmteco portfolio and continues SK pharmteco’s strategy to deliver end-to-end, multi-mod...

September 21, 2023 | Thursday | News
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the strategic r...

September 21, 2023 | Thursday | News
Bristol Myers Squibb Signs $50M Deal to Address Immune-Mediated Diseases in Asia

US-based startup Zenas BioPharma has entered into a license and collaboration agreement with Bristol Myers Squibb Company to develop and commercialise ob...

September 07, 2023 | Thursday | News
Neurophet becomes the inaugural Korean firm selected by Roche Diagnostics for the Startup Creasphere APAC Program

Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the global startup innovation program 'Startu...

September 06, 2023 | Wednesday | News
SK Bioscience, Vaxxas Partner for Needle-Free Typhoid Vaccine Patch

The HD-MAP platform technology offers user-friendly vaccines, allowing possible self-administration. Its room temperature stability revolutionizes distri...

August 24, 2023 | Thursday | News
Amarin and Lotus Pharmaceuticals Partner to Commercialize Vazkepa® in Southeast Asia and South Korea

Amarin Corporation plc (NASDAQ:AMRN) and Lotus Pharmaceuticals (1795:TT; “Lotus”)  announced that the two companies have entered into a lo...

August 01, 2023 | Tuesday | News
South Korea's PharmAbcine Initiates Phase I Trial of Novel TIE2 Antibody in nAMD"

The study, consisting of single ascending-dose cohort and multiple ascending-dose cohort, has dosed the first of 36 planned study subjects. The Phase I cli...

July 27, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in